Remicade/Simponi: Confidential Instructions for Johnson & Johnson Harvard Case Solution & Analysis

This two-party dialogue exercise features a real-life dispute between Merck and Johnson & Johnson viewing European distribution rights to two highly profitable drugs.

PUBLICATION DATE: May 04, 2011 PRODUCT #: 911045-PDF-ENG

This is just an excerpt. This case is about COMMUNICATION

Remicade/Simponi: Confidential Instructions for Johnson & Johnson Case Solution Other Similar Case Solutions like

Remicade/Simponi: Confidential Instructions for Johnson & Johnson

Share This